Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma
- PMID: 17722675
- PMCID: PMC2574298
Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma
Abstract
Primary cutaneous B-cell lymphomas (PCBCLs) are made up of a heterogenous group of B-cell lymphoproliferative diseases confined to the skin at the time of diagnosis with no evidence of extracutaneous involvement. With early diagnosis and adequate treatment, PCBCLs as a group has excellent prognosis, with about a 95% survival rate at five years. We report a case of diffuse large B-cell lymphoma (DLBCL) in a 52-year-old woman presenting as a fungating skin ulcer mimicking advanced basal cell carcinoma. Review of available literature showed most studies of PCBCLs being done on Europeans with no universally acceptable system of classification. Clinical findings, diagnostic evaluations and treatment outcomes of PCBCLs are discussed with emphasis on comparison of European Organization for Research and Treatment of Cancer (EORTC) and the World Health Organization (WHO) Classification of Neoplasms of the Hematopoietic and Lymphoid Tissue classification systems.
Similar articles
-
Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience.Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):719-25. doi: 10.1016/j.ijrobp.2013.07.019. Epub 2013 Aug 31. Int J Radiat Oncol Biol Phys. 2013. PMID: 24001373
-
Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.J Clin Oncol. 1999 Aug;17(8):2471-8. doi: 10.1200/JCO.1999.17.8.2471. J Clin Oncol. 1999. PMID: 10561311
-
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.Lancet. 2013 May 25;381(9880):1817-26. doi: 10.1016/S0140-6736(13)60313-X. Epub 2013 Apr 22. Lancet. 2013. PMID: 23615461 Clinical Trial.
-
[Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].Hautarzt. 2017 Sep;68(9):727-739. doi: 10.1007/s00105-017-4018-0. Hautarzt. 2017. PMID: 28815289 Review. German.
-
Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.J Am Acad Dermatol. 2013 Sep;69(3):343.e1-11; quiz 355-6. doi: 10.1016/j.jaad.2013.06.011. J Am Acad Dermatol. 2013. PMID: 23957985 Review.
Cited by
-
Basal cell carcinoma-mimicking lesions in korean clinical settings.Ann Dermatol. 2014 Aug;26(4):431-6. doi: 10.5021/ad.2014.26.4.431. Epub 2014 Jul 31. Ann Dermatol. 2014. PMID: 25143670 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical